Personalized Medicine Gets a Reprieve: FDA Approves Mararviroc

by: |
08/06/2007

Maraviroc would be the first personalized medicine for AIDS because Pfizer would first test patients to determine whether the drug works for them....

http://news.yahoo.com/s/nm/20070806/bs_nm/pfizer_hiv_dc

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Personalized Medicine Gets a Reprieve: FDA Approves Mararviroc

Latest from CMPI

Coronavirus: America’s drug supply needs a refill

Prescription for Failure: The Ills of Socialized Medicine (CPAC 2020)

How to eliminate surprise medical bills

Keep Canadian drugs out of U.S. medicine cabinets

Blog Roll

Categories